These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2519542)

  • 1. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes.
    Hellström KE; Hellström I
    Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines in lymphoma.
    Levy R
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
    Wang X; Luo W; Foon KA; Ferrone S
    Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
    Castello G; D'Alessio V
    Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotypic tumor vaccines.
    Hellström KE; Hellström I
    Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
    [No Abstract]   [Full Text] [Related]  

  • 6. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
    Ferrone S
    Ann N Y Acad Sci; 1993 Aug; 690():214-24. PubMed ID: 8368740
    [No Abstract]   [Full Text] [Related]  

  • 8. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypes in melanoma.
    Ferrone S
    Hybridoma; 1993 Oct; 12(5):509-14. PubMed ID: 8300123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
    Kageshita T; Hirai S; Ono T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):163-9. PubMed ID: 8311486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
    Li AD; Li Z; Wang YH; Zhang YM; Ma J
    Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic responses induced by tumor: an autocrine network.
    Köhler H; Raychaudhuri S; Chen JJ; Saeki Y
    Int Rev Immunol; 1989; 4(4):311-20. PubMed ID: 2535274
    [No Abstract]   [Full Text] [Related]  

  • 17. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
    Ferrone S; Kageshita T; Hirai S
    J Dermatol; 1993 Sep; 20(9):533-9. PubMed ID: 8227707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
    Wang X; Luo W; Ferrone S
    Medicina (B Aires); 2000; 60 Suppl 2():48-50. PubMed ID: 11188931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
    Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
    J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antibodies in tumour immunotherapy.
    Schultes BC; Nicodemus CF
    Expert Opin Biol Ther; 2004 Aug; 4(8):1265-84. PubMed ID: 15268661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.